Skip to main navigation Skip to search Skip to main content

Human T Cell Lymphotropic Virus Type 1 and Human T Cell Lymphotropic Virus Type 2 Mortality in the Shipibo-Konibo People

  • Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical Alexander von Humboldt
  • Universidad Peruana Cayetano Heredia
  • Hospital Nacional Daniel Alcides Carrion
  • Pontificia Universidad Católica del Perú
  • University of Washington
  • Univ. of Washington Sch. of Med.
  • School of Public Health

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

High rates of human T cell lymphotropic virus type 1 (HTLV-1) and human T cell lymphotropic virus type 2 (HTLV-2) infections have been reported among Andean and Amazonian Peruvian indigenous populations in Peru. The Shipibo-Konibo people are the third-largest Amazonian indigenous group living in Peru. By using data from two observational studies conducted in the Shipibo-Konibo community, we estimated that the risk of all-cause death at 12 years was 3.11 times higher (95% CI: 1.58–6.10) for people with HTLV-1 infection compared with those with HTLV-2 infection or without HTLV-1 and HTLV-2 infections.

Original languageEnglish
Pages (from-to)573-575
Number of pages3
JournalAmerican Journal of Tropical Medicine and Hygiene
Volume113
Issue number3
DOIs
StatePublished - 2025

Fingerprint

Dive into the research topics of 'Human T Cell Lymphotropic Virus Type 1 and Human T Cell Lymphotropic Virus Type 2 Mortality in the Shipibo-Konibo People'. Together they form a unique fingerprint.

Cite this